The Translational Research Cancer Centers Consortium (TRCCC) mission is to gain a greater understanding of the interactions between the immune system and cancer in the setting of biologic therapy of cancer.
TRCCC was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. The organization has successfully brought together leaders in this field to advance science, collaboration, and clinical trials to help individuals diagnosed with cancer.
24th TRCCC Annual Meeting
Please join us February 16 – 18, 2022 at Seven Springs Mountain Resort!
Congratulations Dr. Lotze!
We would like to congratulate to Dr. Michael T. Lotze, MD, one of our founding members, who was recently selected for the very prestigious Lifetime Achievement Award from SITC.